Literature DB >> 11689847

Polymeric system for dual growth factor delivery.

T P Richardson1, M C Peters, A B Ennett, D J Mooney.   

Abstract

The development of tissues and organs is typically driven by the action of a number of growth factors. However, efforts to regenerate tissues (e.g., bone, blood vessels) typically rely on the delivery of single factors, and this may partially explain the limited clinical utility of many current approaches. One constraint on delivering appropriate combinations of factors is a lack of delivery vehicles that allow for a localized and controlled delivery of more than a single factor. We report a new polymeric system that allows for the tissue-specific delivery of two or more growth factors, with controlled dose and rate of delivery. The utility of this system was investigated in the context of therapeutic angiogenesis. We now demonstrate that dual delivery of vascular endothelial growth factor (VEGF)-165 and platelet-derived growth factor (PDGF)-BB, each with distinct kinetics, from a single, structural polymer scaffold results in the rapid formation of a mature vascular network. This is the first report of a vehicle capable of delivery of multiple angiogenic factors with distinct kinetics, and these results clearly indicate the importance of multiple growth factor action in tissue regeneration and engineering.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689847     DOI: 10.1038/nbt1101-1029

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  436 in total

Review 1.  [Tissue engineering in urology. Basic principles and application].

Authors:  G Bartsch; A Atala
Journal:  Urologe A       Date:  2003-02-28       Impact factor: 0.639

2.  Stem cell-calcium phosphate constructs for bone engineering.

Authors:  H H K Xu; L Zhao; M D Weir
Journal:  J Dent Res       Date:  2010-10-06       Impact factor: 6.116

3.  Vascularization of the dermal support enhances wound re-epithelialization by in situ delivery of epidermal keratinocytes.

Authors:  Liana M Lugo; Pedro Lei; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

4.  Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials.

Authors:  Jennifer L Bain; Bonnie K Culpepper; Michael S Reddy; Susan L Bellis
Journal:  Int J Oral Maxillofac Implants       Date:  2014 Nov-Dec       Impact factor: 2.804

5.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

6.  Engineering tissue with BioMEMS.

Authors:  Jeffrey T Borenstein; Gordana Vunjak-Novakovic
Journal:  IEEE Pulse       Date:  2011-11       Impact factor: 0.924

7.  Adipose injury-associated factors mitigate hypoxia in ischemic tissues through activation of adipose-derived stem/progenitor/stromal cells and induction of angiogenesis.

Authors:  Hitomi Eto; Hirotaka Suga; Keita Inoue; Noriyuki Aoi; Harunosuke Kato; Jun Araki; Kentaro Doi; Takuya Higashino; Kotaro Yoshimura
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

8.  Cementum engineering with three-dimensional polymer scaffolds.

Authors:  Q-M Jin; M Zhao; S A Webb; J E Berry; M J Somerman; W V Giannobile
Journal:  J Biomed Mater Res A       Date:  2003-10-01       Impact factor: 4.396

9.  HYDROGEL-BASED NANOCOMPOSITES OF THERAPEUTIC PROTEINS FOR TISSUE REPAIR.

Authors:  Suwei Zhu; Tatiana Segura
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

Review 10.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.